Biologics May Delay Arthritis in Psoriasis Patients Biologics May Delay Arthritis in Psoriasis Patients
Treatment with the interleukin-12/23 inhibitor ustekinumab or interleukin-23 inhibitors was linked to a lower risk of developing psoriatic arthritis compared with tumor necrosis factor inhibitors.MDedge News
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Rheumatology News Source Type: news
More News: Arthritis | Dermatology | Psoriasis | Psoriatic Arthritis | Rheumatology | Skin | Stelara